The bill announced by two Democratic members of the state House of Representatives would guarantee coverage to everyone in the commonwealth—but many of the details have yet to be revealed. The bill announced by two Democratic members of the state House of Representatives would guarantee coverage to everyone in the commonwealth—but many of the details have yet to be revealed. | | |
|
2026 may be the year that many if not most healthcare leaders arrive at a fork in the road to mature AI implementation. 2026 may be the year that many if not most healthcare leaders arrive at a fork in the road to mature AI implementation. | | |
|
The health system said it offered a “historic” 21.5% raise as part of a new contract, but it’s been unable to reach an agreement with union officials. Workers are expected to walk off the job starting Jan. 26. The health system said it offered a “historic” 21.5% raise as part of a new contract, but it’s been unable to reach an agreement with union officials. Workers are expected to walk off the job starting Jan. 26. | | |
|
UnitedHealth Group CEO Stephen Hemsley is expected to make the announcement in front of Congress, where he will also offer other policy solutions. The company said it’s still working out details on how to best distribute its profits to customers. UnitedHealth Group CEO Stephen Hemsley is expected to make the announcement in front of Congress, where he will also offer other policy solutions. The company said it’s still working out details on how to best distribute its profits to customers. | | |
|
The U.S. Department of Justice announced four more guilty pleas on Thursday, bringing the total to 12. The scheme involved providers paying kickbacks to patients, all employees of Amtrak, in exchange for billing their insurance for unnecessary medical care. The incidents happened between 2019 and 2022. The U.S. Department of Justice announced four more guilty pleas on Thursday, bringing the total to 12. The scheme involved providers paying kickbacks to patients, all employees of Amtrak, in exchange for billing their insurance for unnecessary medical care. The incidents happened between 2019 and 2022. | | |
|
Traditional fee-for-service Medicare saw a slight dip in improper payments, which are usually associated with documentation errors and now outright fraud. CMS also released data on Medicaid and the CHIP program. Traditional fee-for-service Medicare saw a slight dip in improper payments, which are usually associated with documentation errors and now outright fraud. CMS also released data on Medicaid and the CHIP program. | | |
|
Where have the missing rural American hospitals gone? And where is rural healthcare headed? The discussion is on in Washington and elsewhere. Where have the missing rural American hospitals gone? And where is rural healthcare headed? The discussion is on in Washington and elsewhere. | | |
|
Boston Scientific sent all known customers a letter on December 19, 2025 alerting them to an issue with certain AXIOS Stent and Electrocautery Enhanced Delivery Systems. During deployment, the stents may not expand. This can cause severe, potentially life-threatening injury to patients. All recalled stents must be removed from clinical settings immediately. Boston Scientific sent all known customers a letter on December 19, 2025 alerting them to an issue with certain AXIOS Stent and Electrocautery Enhanced Delivery Systems. During deployment, the stents may not expand. This can cause severe, potentially life-threatening injury to patients. All recalled stents must be removed from clinical settings immediately. | | |
|
The Missouri complaint mirrors those brought by the Federal Trade Commission, the state of Texas and Philadelphia-based Jefferson Health, among others, in that it’s focused on alleged collusion between pharmacy benefit managers and drug companies to control the price of insulin. The Missouri complaint mirrors those brought by the Federal Trade Commission, the state of Texas and Philadelphia-based Jefferson Health, among others, in that it’s focused on alleged collusion between pharmacy benefit managers and drug companies to control the price of insulin. | | |
|
Just because a healthcare AI product gets loudly promoted doesn’t mean its claims are bogus. The salient question is whether or not it performs as well in a clinical setting as it did in a research lab—or in a marketer’s mind. Just because a healthcare AI product gets loudly promoted doesn’t mean its claims are bogus. The salient question is whether or not it performs as well in a clinical setting as it did in a research lab—or in a marketer’s mind. | | |
|
